Loading clinical trials...

Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT | Clinical Trials | Clareo Health

COMPLETED

Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

NCT05289583•Evangelisches Krankenhaus Bielefeld gGmbH

View on ClinicalTrials.gov

Summary

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•three or more criteria for BPD as defined by DSM-5 (Borderline Personality characteristics; BPC)

Exclusion Criteria

•inability to contract and consent,
•other severe mental disorders (bipolar disorder, acute psychosis),
•current alcohol,
•illicit or not prescribed drug use,
•simultaneous participation in other treatment studies,
•pregnancy or breastfeeding,
•an inability to negotiate a non-suicide agreement,
•ongoing traumatic contact with the perpetrator, and
•a Body Mass Index \< 16.5.

Locations (1)

Research Department

Bielefeld, Germany

Key Dates

Start Date

January 1, 2019

Primary Completion Date

December 31, 2021

Completion Date

February 28, 2022

Last Updated

April 1, 2022

Enrollment

ACTUAL participants

Conditions

Borderline Personality DisorderPsychotherapyDropout

Interventions

Dialectical Behavior Therapy

BEHAVIORAL

Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

NCT07147205

PsychotherapyIntegrative Medicine

View study

RECRUITINGNA

Internal Family Systems Therapy for Borderline Personality Disorder

NCT07342907

Borderline Personality Disorder (BPD)

View study

RECRUITINGNA

Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 1, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

Inclusion Criteria

Exclusion Criteria

Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

Internal Family Systems Therapy for Borderline Personality Disorder

Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder

NEUROIMAGING OF ADOLESCENT BORDERLINE PERSONALITY DISORDER WITH AND WITHOUT POST-TRAUMATIC STRESS DISORDER

Psychological Treatment to Support the Consequences of Cognitive Impairment

Application and Effectiveness of the STEPPS in Patients with BPD, Extending to Their Families with the FC Program